N-methylformamide (NSC 3051): a potenial candidate for combination chemotherapy
- 1 June 1985
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 21 (6) , 745-752
- https://doi.org/10.1016/0277-5379(85)90273-1
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Studies on the toxicity of the antitumour agent N-methylformamide in mice☆Toxicology, 1985
- An investigation of the mechanism of hepatotoxicity of the antitumour agent N-methylformamide in miceBiochemical Pharmacology, 1984
- INHIBITION OF THE GROWTH OF HUMAN-COLON CANCER XENOGRAFTS BY POLAR-SOLVENTS1982
- Reaction-Rate Assay of Serum Sorbitol Dehydrogenase Activity at 37 °CClinical Chemistry, 1975
- Hepatotoxic effects of methotrexateCancer, 1966
- STUDIES ON MECHANISM OF ACTION OF CYTOXAN EVIDENCE OF ACTIVATION IN VIVO AND IN VITRO1961
- Studies on the folic acid vitamins.II. The Acute toxicity of amethopterin in manCancer, 1960
- The hepatotoxic action ofN-methylformamide in manCancer, 1956
- NITROGEN MUSTARD THERAPY IN HODGKIN’S DISEASEBlood, 1949
- A SIMPLIFIED METHOD OF EVALUATING DOSE-EFFECT EXPERIMENTS1949